Abstract
In monitoring the effects of industrial exposure resulting from the pharmaceutical manufacture of oestrogen-progestogen combinations by coagulation studies acceleration of some clotting tests was found. The most pronounced changes were in workers most closely associated with the industrial process. Less pronounced changes were found in women employees not closely concerned with the processing and may have been secondary to the postmenopausal bleeding to which they were prone. A safer work procedure elaborated by the Employment Medical Advisory Service was monitored by clotting studies for over a year but the three most highly exposed subjects showed no substantial improvement.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amris C. J., Starup J. The coagulation mechanism in oral contraception. Acta Obstet Gynecol Scand. 1967;46(1):78–91. doi: 10.3109/00016346709158628. [DOI] [PubMed] [Google Scholar]
- HOUGIE C., RUTHERFORD R. N., BANKS A. L., COBURN W. A. EFFECT OF A PROGESTIN-ESTROGEN ORAL CONTRACEPTIVE ON BLOOD CLOTTING FACTORS. Metabolism. 1965 Mar;14:SUPPL–SUPPL:417. doi: 10.1016/0026-0495(65)90027-2. [DOI] [PubMed] [Google Scholar]
- MILLER S. P., LEE S. L., RITZ N. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY. Metabolism. 1965 Mar;14:SUPPL–SUPPL:410. doi: 10.1016/0026-0495(65)90026-0. [DOI] [PubMed] [Google Scholar]
- Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand. 1967;46(3):286–303. doi: 10.3109/00016346709158633. [DOI] [PubMed] [Google Scholar]
- THOMSON J. M., POLLER L. ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY. Br Med J. 1965 Jul 31;2(5456):270–273. doi: 10.1136/bmj.2.5456.270. [DOI] [PMC free article] [PubMed] [Google Scholar]